Variation in the value of total shoulder arthroplasty

Background: There is growing interest in maximizing value for patients undergoing discretionary orthopedic surgery but little data to guide improvement efforts. Integrating patient-reported outcomes with time-driven activity-based costing, we explored patient-level variation in the value of total shoulder arthroplasty (TSA) and characterized factors that contribute to this variation. Methods: Using our institutional registry, we identified 239 patients undergoing elective primary TSA (anatomic or reverse) between 2016-2017 with minimum 2-year follow-up. We calculated value as 2-year postoperative American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES) scores divided by hospitalization time-driven activity-based costs. This number was multiplied by a constant to set the minimum value of TSA to 100. Multivariable linear regression modeling was performed to characterize factors underlying variation in value. Results: The value of shoulder arthroplasty ranged from 100 to 680, resulting in a variation of 580%. Reverse shoulder arthroplasty was associated with decreased value (79-point decrease vs. anatomic arthroplasty; P < .001; partial R2 = 0.089), as were prior ipsilateral shoulder surgery (38-point decrease; P = .002; partial R2 = 0.031), more self-reported allergies (4-point decrease per 1-unit increase; P = .029; partial R2 = 0.015), diabetes (33-point decrease; P = .045; partial R2 = 0.013), and lower preoperative ASES score (0.7-point increase per 1-unit increase; P = .045; partial R2 = 0.012). Conclusions: We observed wide variation in the value of shoulder arthroplasty that was most strongly associated with procedure type and certain preoperative characteristics (eg, prior shoulder surgery, number of self-reported allergies, diabetes, ASES score). Awareness of these associations is important for implementation of targeted strategies to effectively reduce variation and redirect resources toward higher-value, cost-conscious care. Level of evidence: Level IV; Economic Analysis (c) 2020 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights reserved.